| NDC Code: |
25021-207 |
| Proprietary Name: |
doxorubicin hydrochloride |
| Suffix: |
|
| Non-Proprietary Name: |
doxorubicin hydrochloride |
| Dosage Form: |
INJECTION, SOLUTION |
| Method: |
INTRAVENOUS |
| Original Marketing Date: |
31-10-2013 |
| Category Name: |
ANDA |
| Application Number: |
ANDA091495 |
| Labeler: |
SAGENT PHARMACEUTICALS |
| Substance Name: |
DOXORUBICIN HYDROCHLORIDE |
| Active Numerator Strength: |
2 |
| Active Ingredient Unit: |
mg/mL |
| Pharm Classes: |
Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA] |
| DEA Schedule: |
|
